FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Peter Falkai

Research Profile

Disorders

Anatomy

Concepts & Ideas

Activities & Behaviors

Co-author Network

Publications

TOP 3
Thomas Wobrock; Han Boter; M Davidson; Eske Derks; S Dollfus; Peter Falkai; W Wolfgang Fleischhacker; Wolfgang Gaebel; Silvana Galderisi; A Hasan; L G Hranov; René S Kahn; Jan Libiger; Juan J López-Ibor; Joseph Peuskens; Janusz K Rybakowski; Thomas Schneider-Axmann
Comorbid substance abuse in first-episode schizophrenia: Effects on cognition and psychopathology in the EUFEST study.
Ulrich Palm; Peter Falkai; Alkomiet Hasan; Daniel Keeser; Frank Padberg
Transcranial random noise stimulation for the treatment of negative symptoms in schizophrenia.
David Zilles; Raphael Jung; Peter Falkai; Eva Gruber; Oliver Gruber
Differential working memory performance as support for the Kraepelinian dichotomy between schizophrenia and bipolar disorder? An experimental neuropsychological study using circuit-specific working memory tasks.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Peter Falkai (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Thomas Wobrock; Han Boter; M Davidson; Eske Derks; S Dollfus; Peter Falkai; W Wolfgang Fleischhacker; Wolfgang Gaebel; Silvana Galderisi; A Hasan; L G Hranov; René S Kahn; Jan Libiger; Juan J López-Ibor; Joseph Peuskens; Janusz K Rybakowski; Thomas Schneider-Axmann
Comorbid substance abuse in first-episode schizophrenia: Effects on cognition and psychopathology in the EUFEST study.
Schizophrenia research 2013;147(1):132-9.
2013: Ulrich Palm; Peter Falkai; Alkomiet Hasan; Daniel Keeser; Frank Padberg
Transcranial random noise stimulation for the treatment of negative symptoms in schizophrenia.
Schizophrenia research 2013;146(1-3):372-3.
2013: David Zilles; Raphael Jung; Peter Falkai; Eva Gruber; Oliver Gruber
Differential working memory performance as support for the Kraepelinian dichotomy between schizophrenia and bipolar disorder? An experimental neuropsychological study using circuit-specific working memory tasks.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2013;14(4):258-67.
2013: Andrea Schmitt; Peter Falkai
Risk genes, metabolic syndrome and eye tracking deficits in psychiatric diseases.
European archives of psychiatry and clinical neuroscience 2013;263(3):177-9.
2013: Alkomiet Hasan; Sven Bestmann; Elias P Casula; Peter Falkai; Joseph M Galea; John C Rothwell
Muscle and timing-specific functional connectivity between the dorsolateral prefrontal cortex and the primary motor cortex.
Journal of cognitive neuroscience 2013;25(4):558-70.
2013: I Großimlinghaus; B Janssen; D Reich-Erkelenz; T Wobrock; Peter Falkai; W Gaebel; J Zielasek
[Developmental process of DGPPN quality indicators].
Der Nervenarzt 2013;84(3):350-65.
2013: Andrea Schmitt; Peter Falkai
Differential diagnosis of major depression and bipolar disorder.
European archives of psychiatry and clinical neuroscience 2013;263(2):83-4.
2013: Andrea Pfennig; Tom Bschor; Peter Falkai; Michael Bauer
The diagnosis and treatment of bipolar disorder: recommendations from the current s3 guideline.
Deutsches Ärzteblatt international 2013;110(6):92-100.
2013: Andrea Schmitt; Peter Falkai
Schizophrenia: brain morphology and treatment aspects.
European archives of psychiatry and clinical neuroscience 2013;263(1):1-2.
2013: Alkomiet Hasan; Jeffrey Lieberman; Hans-Jürgen Möller; Florence Thibaut; Thomas Wobrock; Peter Falkai; Wagner F Gattaz; Birte Y Glenthoj
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 2: update 2012 on the long-term treatment of schizophrenia and management of antipsychotic-induced side effects.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2013;14(1):2-44.
2013: S Trost; J Usher; Thomas Wobrock; S Ekawardhani; Peter Falkai; J Meyer; B Platz; W Reith; Harald Scherk; Oliver Gruber
DISC1 (disrupted-in-schizophrenia 1) is associated with cortical grey matter volumes in the human brain: a voxel-based morphometry (VBM) study.
Journal of psychiatric research 2013;47(2):188-96.
2013: Berend Malchow; Andrea Schmitt; Peter Falkai; Paolo Fusar-Poli; Alkomiet Hasan; Thomas Wobrock
Cannabis abuse and brain morphology in schizophrenia: a review of the available evidence.
European archives of psychiatry and clinical neuroscience 2013;263(1):3-13.
2013: S Trost; J Usher; Thomas Wobrock; S Ekawardhani; Peter Falkai; J Meyer; B Platz; Wolfgang Reith; Harald Scherk; Oliver Gruber
The DTNBP1 (dysbindin-1) gene variant rs2619522 is associated with variation of hippocampal and prefrontal grey matter volumes in humans.
European archives of psychiatry and clinical neuroscience 2013;263(1):53-63.
2013: Birgit Guse; Alkomiet Hasan; Andrew McIntosh; K Obst; Boris Suchan; Heather Whalley; Peter Dechent; Peter Falkai; Lydia Gibson; Oliver Gruber; Thomas Wobrock
The effect of long-term high frequency repetitive transcranial magnetic stimulation on working memory in schizophrenia and healthy controls--a randomized placebo-controlled, double-blind fMRI study.
Behavioural brain research 2013;237():300-7.
2013: Alkomiet Hasan; Wolfgang Retz; Michael Rösler; Diane Ruge; Marc Schneider; Thomas Schneider-Axmann; Peter Falkai; Thomas Wobrock
A similar but distinctive pattern of impaired cortical excitability in first-episode schizophrenia and ADHD.
Neuropsychobiology 2013;67(2):74-83.
2013: Evelin L Schaeffer; Angelika Schmitt; Thomas Schneider-Axmann; Peter Falkai; Wagner F Gattaz; Oliver Gruber; Franziska Kühn; Andrea Schmitt
Increased cell proliferation in the rat anterior cingulate cortex following neonatal hypoxia: relevance to schizophrenia.
Journal of neural transmission (Vienna, Austria : 1996) 2013;120(1):187-95.
2012: Andrea Schmitt; Peter Falkai
Post-mortem findings in mood disorders, nightmares and therapeutic approaches of psychiatric diseases.
European archives of psychiatry and clinical neuroscience 2012;262(8):635-6.
2012: Pascal F Durrenberger; Peter Falkai; Francisca S Fernando; Isidro Ferrer; Peter J Gebicke-Haerter; Edna Grünblatt; Samira N Kashefi; Hans A Kretzschmar; Roberta Magliozzi; Brahim Nait-Oumesmar; Miklos Palkovits; Piero Parchi; Thomas Arzberger; Timothy P Bonnert; Sabina Capellari; David T Dexter; Federico Roncaroli; Andrea Schmitt; Danielle Seilhean; Richard Reynolds
Selection of novel reference genes for use in the human central nervous system: a BrainNet Europe Study.
Acta neuropathologica 2012;124(6):893-903.
2012: David Zilles; Jobst Meyer; Thomas Schneider-Axmann; Savira Ekawardhani; Peter Falkai; Eva Gruber; Oliver Gruber
Genetic polymorphisms of 5-HTT and DAT but not COMT differentially affect verbal and visuospatial working memory functioning.
European archives of psychiatry and clinical neuroscience 2012;262(8):667-76.
2012: Esther Kristina Diekhof; Peter Falkai; Jürgen Baudewig; Peter Dechent; Lesly Nerenberg; Oliver Gruber
Impulsive personality and the ability to resist immediate reward: an fMRI study examining interindividual differences in the neural mechanisms underlying self-control.
Human brain mapping 2012;33(12):2768-84.
2012: Peter Falkai
[The future of psychosocial medicine].
Der Nervenarzt 2012;83(11):1363.
2012: Andrea Schmitt; Oliver Gruber; Peter Falkai
Selected issues of the DGPPN Congress in 2011.
European archives of psychiatry and clinical neuroscience 2012;262 Suppl 2():S49-50.
2012: Alkomiet Hasan; Joachim Klosterkötter; Marcin Labusga; Katrin Levold; Hendrik Müller; Thomas Schneider-Axmann; Thomas Wobrock; Peter Falkai; Christian Grefkes; Andreas Bechdolf
Deficient inhibitory cortical networks in antipsychotic-naive subjects at risk of developing first-episode psychosis and first-episode schizophrenia patients: a cross-sectional study.
Biological psychiatry 2012;72(9):744-51.
2012: Peter Falkai; Andrea Schmitt
On our own behalf: a new editorial board and focus of EAPCN.
European archives of psychiatry and clinical neuroscience 2012;262(7):545-6.
2012: Andrea Schmitt; Peter Falkai
Schizophrenia: from risk genes to outcome and comorbidity.
European archives of psychiatry and clinical neuroscience 2012;262(7):547-8.
2012: Andrea Schmitt; Rainer Spanagel; Sven P Wichert; Mathias Zink; Thomas Arzberger; Pascal F Durrenberger; Peter Falkai; Mario Herrera-Marschitz; Hans Kretzschmar; Fernando Leonardi-Essmann; Richard Reynolds; Moritz J Rossner; Peter J Gebicke-Haerter
Structural synaptic elements are differentially regulated in superior temporal cortex of schizophrenia patients.
European archives of psychiatry and clinical neuroscience 2012;262(7):565-77.
2012: Leonhard Lennertz; Wolfgang Maier; Ralf Pukrop; Friederike Rampacher; Stephan Ruhrmann; Svenja Schulze-Rauschenbach; Andrea Vogeley; Peter Falkai; Joachim Klosterkötter; Michael Wagner
Antisaccade performance in patients with obsessive-compulsive disorder and unaffected relatives: further evidence for impaired response inhibition as a candidate endophenotype.
European archives of psychiatry and clinical neuroscience 2012;262(7):625-34.
2012: Alkomiet Hasan; Maximiliane Herrmann; Louise Marshall; Michael A Nitsche; Thomas Schneider-Axmann; Peter Falkai; Oliver Gruber; Thomas Wobrock
Impaired long-term depression in schizophrenia: a cathodal tDCS pilot study.
Brain stimulation 2012;5(4):475-83.
2012: Esther K Diekhof; Peter Falkai; Ilona Henseler; Maria Keil; Katrin U Obst; Peter Dechent; Oliver Gruber
A functional neuroimaging study assessing gender differences in the neural mechanisms underlying the ability to resist impulsive desires.
Brain research 2012;1473():63-77.
2012: Borwin Bandelow; Karl-Heinz Biesold; Manuel Koch; Dirk Wedekind; Peter Zimmermann; Peter Falkai
Posttraumatic stress disorder (PTSD) in the German Armed Forces: a retrospective study in inpatients of a German army hospital.
European archives of psychiatry and clinical neuroscience 2012;262(6):459-67.
2012: Peter Falkai; Hans-Jürgen Möller
Biomarkers and neurobiology of schizophrenia.
European archives of psychiatry and clinical neuroscience 2012;262(5):363-4.
2012: Alkomiet Hasan; Louise Marshall; Michael A Nitsche; Andrea Schmitt; Richard Aborowa; Peter Falkai; Oliver Gruber; Thomas Wobrock
Abnormal bihemispheric responses in schizophrenia patients following cathodal transcranial direct stimulation.
European archives of psychiatry and clinical neuroscience 2012;262(5):415-23.
2012: Alkomiet Hasan; Jeffrey Lieberman; Hans-Jürgen Möller; Florence Thibaut; Thomas Wobrock; Peter Falkai; Wagner F Gattaz; Birte Glenthoj
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, part 1: update 2012 on the acute treatment of schizophrenia and the management of treatment resistance.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2012;13(5):318-78.
2012: Peter Falkai; Hans-Jürgen Möller
From pathophysiological aspects towards unravelling the neurobiological background of cognitive deficits.
European archives of psychiatry and clinical neuroscience 2012;262(4):275-6.
2012: Esther Kristina Diekhof; Peter Falkai; Lisa Kaps; Oliver Gruber
The role of the human ventral striatum and the medial orbitofrontal cortex in the representation of reward magnitude - an activation likelihood estimation meta-analysis of neuroimaging studies of passive reward expectancy and outcome processing.
Neuropsychologia 2012;50(7):1252-66.
2012: Sabine Herpertz; Peter Falkai
[Future of medical psychotherapy in psychiatry].
Psychiatrische Praxis 2012;39(4):151-2.
2012: Peter Falkai; Hans-Jürgen Möller
Psychopathology: genetics and the stress-vulnerability hypothesis.
European archives of psychiatry and clinical neuroscience 2012;262(3):181-2.
2012: Peter Falkai; Hans-Jürgen Möller
Neurobiology of schizophrenia: from outcome to pathophysiological insights.
European archives of psychiatry and clinical neuroscience 2012;262(2):93-4.
2012: Jeeva Varadarajulu; Murtada Alsaif; Peter Falkai; Andrea Schmitt; Christoph W Turck; Daniel Martins-de-Souza
Differential expression of HINT1 in schizophrenia brain tissue.
European archives of psychiatry and clinical neuroscience 2012;262(2):167-72.
2012: Peter Falkai; Hans-Jürgen Möller
Emotional status: diagnosis and treatment for severe psychiatric disorders.
European archives of psychiatry and clinical neuroscience 2012;262(1):1-2.
2012: Oliver Gruber; Alkomiet Hasan; Jobst Meyer; Wolfgang Reith; Harald Scherk; Andrea Schmitt; Thomas Schneider-Axmann; Thomas Wobrock; Martin Backens; Savira Ekawardhani; Peter Falkai
Association of the brain-derived neurotrophic factor val66met polymorphism with magnetic resonance spectroscopic markers in the human hippocampus: in vivo evidence for effects on the glutamate system.
European archives of psychiatry and clinical neuroscience 2012;262(1):23-31.
2012: Gregor Habl; Alexander Jatzko; Andrea Schmitt; Thomas Schneider-Axmann; Martina Von Wilmsdorff; Peyman Yeganeh-Doost; Mathias Zink; Manfred Bauer; Peter Falkai
Decreased reelin expression in the left prefrontal cortex (BA9) in chronic schizophrenia patients.
Neuropsychobiology 2012;66(1):57-62.
2011: Peter Falkai; Jörg M Fegert
[Sexual abuse and the consequences. This concerns all doctors].
MMW Fortschritte der Medizin 2011;153(51-52):29.
2011: Peter Falkai; Hans-Jürgen Möller
Mood disorders in the light of genes, comorbidity and contemporary treatment.
European archives of psychiatry and clinical neuroscience 2011;261(8):531-2.
2011: Peter Falkai
[Personalized psychiatry and psychotherapy. Realistic hope for the future or fiction?].
Der Nervenarzt 2011;82(11):1382, 1384.
2011: Wolfgang Jordan; Johann Steiner; Regina W von Einsiedel; Lothar Adler; Stefan Bleich; Peter Falkai; Volker Grosskopf; Iris Hauth; Stefan Cohrs
[Shortage of doctors in psychiatric hospitals--providing for the future by reorganizing medical services].
Psychiatrische Praxis 2011;38 Suppl 2():S16-24.
2011: Wolfgang Jordan; Johann Steiner; Regina W von Einsiedel; Stefan Bleich; Stefan Cohrs; Peter Falkai; Volker Grosskopf; Iris Hauth; Lothar Adler
[Definition of the core area of medical services in the psychiatric-psychotherapeutic field--the prerequisite for any delegation].
Psychiatrische Praxis 2011;38 Suppl 2():S8-15.
2011: Wolfgang Jordan; Regina W von Einsiedel; Lothar Adler; Stefan Bleich; Stefan Cohrs; Peter Falkai; Volker Grosskopf; Iris Hauth; Johann Steiner
[Legal aspects of delegation and reorganisation of medical services in the psychiatric field].
Psychiatrische Praxis 2011;38 Suppl 2():S1-7.
2011: Andrea Schmitt; Oliver Gruber; Alkomiet Hasan; Peter Falkai
Schizophrenia as a disorder of disconnectivity.
European archives of psychiatry and clinical neuroscience 2011;261 Suppl 2():S150-4.
2011: Wolfgang Wölwer; Wilhelm Burtscheidt; Peter Falkai; Petra E Franke; Nicole Frommann; Michaela Jänner; Thomas Kuhlmann; Bodo Lieb; Wolfgang Maier; Christian Ohmann; Michael Radermacher; Norbert Scherbaum; Christian Schütz; Thomas Wobrock; Wolfgang Gaebel
The effects of combined acamprosate and integrative behaviour therapy in the outpatient treatment of alcohol dependence: a randomized controlled trial.
Drug and alcohol dependence 2011;118(2-3):417-22.
2011: Camelia-Maria Monoranu; Wolfgang Roggendorf; Andrea Schmitt; Safa Al-Saraj; Manuela Apfelbacher; Jasmin Bartl; Jürgen Deckert; Peter Falkai; Isidro Ferrer; Edna Grünblatt; Daniela Keller; Andrea Meyer; Tanja M Michel; Peter Riederer
Methyl- and acetyltransferases are stable epigenetic markers postmortem.
Cell and tissue banking 2011;12(4):289-97.
2011: Athanasios Zovoilis; Pooja Rao; Farahnaz Sananbenesi; Andrea Schmitt; Roman M Stilling; Hope Y Agbemenyah; Roberto C Agis-Balboa; Sanaz Bahari-Javan; Susanne Burkhardt; Ivana Delalle; Dieter Edbauer; Peter Falkai; Laurent Farinelli; Andre Fischer
microRNA-34c is a novel target to treat dementias.
The EMBO journal 2011;30(20):4299-308.
2011: Alkomiet Hasan; Michael A Nitsche; Bettina Rein; Thomas Schneider-Axmann; Peter Falkai; Oliver Gruber; Birgit Guse; Thomas Wobrock
Dysfunctional long-term potentiation-like plasticity in schizophrenia revealed by transcranial direct current stimulation.
Behavioural brain research 2011;224(1):15-22.
2011: Peter Falkai; Hans-Jürgen Möller
From generation of biomarkers to treatment and psychosocial aspects of psychosis.
European archives of psychiatry and clinical neuroscience 2011;261(7):457-8.
2011: Alkomiet Hasan; Stephen M Lawrie; Wolfgang Maier; Andrew M McIntosh; Thomas William Moorhead; Thomas Schneider-Axmann; Ralf Tepest; Uta-Aglaia Droese; Peter Falkai; Thomas Wobrock
Prefrontal cortex gyrification index in twins: an MRI study.
European archives of psychiatry and clinical neuroscience 2011;261(7):459-65.
2011: Andrea Schmitt; Thomas Schneider-Axmann; Wiebke Schulenberg; Johann Steiner; Peyman Yeganeh-Doost; Hans-Gert Bernstein; Bernhard Bogerts; Oliver Gruber; Alkomiet Hasan; Berend Malchow; Peter Falkai
Reduction of gyrification index in the cerebellar vermis in schizophrenia: a post-mortem study.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2011;12 Suppl 1():99-103.
2011: Peter Falkai; Hans-Jürgen Möller
Achievement and maintenance of the new impact factor 2010.
European archives of psychiatry and clinical neuroscience 2011;261(6):387-9.
2011: Esther Kristina Diekhof; Peter Falkai; Katharina Geier; Oliver Gruber
Fear is only as deep as the mind allows: a coordinate-based meta-analysis of neuroimaging studies on the regulation of negative affect.
NeuroImage 2011;58(1):275-85.
2011: Alkomiet Hasan; Lisa Kremer; Oliver Gruber; Thomas Schneider-Axmann; Birgit Guse; Wolfgang Reith; Peter Falkai; Thomas Wobrock
Planum temporale asymmetry to the right hemisphere in first-episode schizophrenia.
Psychiatry research 2011;193(1):56-9.
2011: Sabrina Grube; Martin F Gerchen; Bartosz Adamcio; Luis A Pardo; Sabine Martin; Dörthe Malzahn; Sergi Papiol; Martin Begemann; Katja Ribbe; Heidi Friedrichs; Konstantin A Radyushkin; Michael Müller; Fritz Benseler; Joachim Riggert; Peter Falkai; Heike Bickeböller; Klaus-Armin Nave; Nils Brose; Walter Stühmer; Hannelore Ehrenreich
A CAG repeat polymorphism of KCNN3 predicts SK3 channel function and cognitive performance in schizophrenia.
EMBO molecular medicine 2011;3(6):309-19.
2011: Magdalena M Brzózka; André Fischer; Peter Falkai; Ursula Havemann-Reinecke
Acute treatment with cannabinoid receptor agonist WIN55212.2 improves prepulse inhibition in psychosocially stressed mice.
Behavioural brain research 2011;218(2):280-7.
2011: Giorgio Giaccone; Thomas Arzberger; Irina Alafuzoff; Safa Al-Sarraj; Herbert Budka; Charles Duyckaerts; Peter Falkai; Isidro Ferrer; James W Ironside; Gábor G Kovács; David Meyronet; Piero Parchi; Efstratios Patsouris; Tamas Revesz; Peter Riederer; Annemieke Rozemuller; Andrea Schmitt; Bengt Winblad; Hans A Kretzschmar
New lexicon and criteria for the diagnosis of Alzheimer's disease.
Lancet neurology 2011;10(4):298-9; author reply 300-1.
2011: Esther Kristina Diekhof; Peter Falkai; Oliver Gruber
The orbitofrontal cortex and its role in the assignment of behavioural significance.
Neuropsychologia 2011;49(5):984-91.
2011: Andrea Schmitt; Fernando Leonardi-Essmann; Pascal F Durrenberger; Eleni Parlapani; Thomas Schneider-Axmann; Rainer Spanagel; Thomas Arzberger; Hans A Kretzschmar; Mario Herrera-Marschitz; Oliver Gruber; Richard Reynolds; Peter Falkai; Peter J Gebicke-Haerter
Regulation of immune-modulatory genes in left superior temporal cortex of schizophrenia patients: a genome-wide microarray study.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2011;12(3):201-15.
2011: Oliver Gruber; David Zilles; Jennifer Kennel; Eva Gruber; Peter Falkai
A systematic experimental neuropsychological investigation of the functional integrity of working memory circuits in major depression.
European archives of psychiatry and clinical neuroscience 2011;261(3):179-84.
2011: Peter Falkai; Hans-Jürgen Möller
The functional sequelae of schizophrenia: consequences of long-term pharmacotherapy and the neurobiology of addiction.
European archives of psychiatry and clinical neuroscience 2011;261(2):83-4.
2011: Dirk Wedekind; Karolin Neumann; Peter Falkai; Berend Malchow; Kirsten Rita Engel; Katja Jamrozinski; Ursula Havemann-Reinecke
S100B and homocysteine in the acute alcohol withdrawal syndrome.
European archives of psychiatry and clinical neuroscience 2011;261(2):133-8.
2011: Peter Falkai
A desperate search for biomarkers in schizophrenia. What is going wrong?
World psychiatry : official journal of the World Psychiatric Association (WPA) 2011;10(1):38-9.
2011: Esther K Diekhof; Hanne E Kipshagen; Peter Falkai; Peter Dechent; Jürgen Baudewig; Oliver Gruber
The power of imagination--how anticipatory mental imagery alters perceptual processing of fearful facial expressions.
NeuroImage 2011;54(2):1703-14.
2011: Torsten Wüstenberg; M Begemann; C Bartels; O Gefeller; S Stawicki; D Hinze-Selch; A Mohr; Peter Falkai; J B Aldenhoff; M Knauth; K-A Nave; Hannelore Ehrenreich
Recombinant human erythropoietin delays loss of gray matter in chronic schizophrenia.
Molecular psychiatry 2011;16(1):26-36, 1.
2010: Peter Falkai; Hans-Jürgen Möller
Sleep, hypothalamus, and stigma.
European archives of psychiatry and clinical neuroscience 2010;260(8):563-4.
2010: Dirk Wedekind; Thomas Herchenhein; Julia Kirchhainer; Borwin Bandelow; Peter Falkai; Kirsten Engel; Berend Malchow; Ursula Havemann-Reinecke
Serotonergic function, substance craving, and psychopathology in detoxified alcohol-addicted males undergoing tryptophan depletion.
Journal of psychiatric research 2010;44(16):1163-9.
2010: Daniel Martins-de-Souza; Giuseppina Maccarrone; Thomas Wobrock; Inga Zerr; Philipp Gormanns; Stefan Reckow; Peter Falkai; Andrea Schmitt; Christoph W Turck
Proteome analysis of the thalamus and cerebrospinal fluid reveals glycolysis dysfunction and potential biomarkers candidates for schizophrenia.
Journal of psychiatric research 2010;44(16):1176-89.
2010: Katrin Radenbach; V Flaig; Thomas Schneider-Axmann; J Usher; Wolfgang Reith; Peter Falkai; Oliver Gruber; Harald Scherk
Thalamic volumes in patients with bipolar disorder.
European archives of psychiatry and clinical neuroscience 2010;260(8):601-7.
2010: J U Sommer; Andrea Schmitt; M Heck; E L Schaeffer; M Fendt; Mathias Zink; K Nieselt; S Symons; G Petroianu; A Lex; M Herrera-Marschitz; R Spanagel; Peter Falkai; Peter J Gebicke-Haerter
Differential expression of presynaptic genes in a rat model of postnatal hypoxia: relevance to schizophrenia.
European archives of psychiatry and clinical neuroscience 2010;260 Suppl 2():S81-9.
2010: A Schneider; Peter Falkai; Andreas Papassotiropoulos
[Molecular principles of tau-induced toxicity: new experimental therapy strategies for treatment of Alzheimer's disease].
Der Nervenarzt 2010;81(11):1289-90, 1292, 1294, passim.
2010: Peter Falkai; Hans-Jürgen Möller
Biomarkers, population-based studies and a proof of principle investigation in pharmacotherapy.
European archives of psychiatry and clinical neuroscience 2010;260(7):507-8.
2010: Daniel Martins-de-Souza; Andrea Schmitt; Ruth Röder; Maria Lebar; Thomas Schneider-Axmann; Peter Falkai; Christoph W Turck
Sex-specific proteome differences in the anterior cingulate cortex of schizophrenia.
Journal of psychiatric research 2010;44(14):989-91.
2010: David Zilles; Eva Gruber; Peter Falkai; Oliver Gruber
Patients with schizophrenia show deficits of working memory maintenance components in circuit-specific tasks.
European archives of psychiatry and clinical neuroscience 2010;260(7):519-25.
2010: Berend Malchow; Peter Falkai; Thomas Wobrock
[The speechless patient].
MMW Fortschritte der Medizin 2010;152(38):25-8.
2010: Peter Falkai
[Tears, rage, silence: patients in state of emergency].
MMW Fortschritte der Medizin 2010;152(38):24.
2010: Peter Falkai; Hans-Jürgen Möller
Understanding mental disorders from neuronal networks to glial cells and proteomics.
European archives of psychiatry and clinical neuroscience 2010;260(6):441-2.
2010: T Wobrock; F Schneider; Peter Falkai
[Guideline intentions of the German Society of Psychiatry, Psychotherapy and Nervous Diseases (DGPPN)].
Der Nervenarzt 2010;81(9):1041-8.
2010: Thomas Wobrock; Oliver Gruber; Andrew M McIntosh; Susanne Kraft; Anne Klinghardt; Harald Scherk; Wolfgang Reith; Thomas Schneider-Axmann; Stephen M Lawrie; Peter Falkai; Thomas William Moorhead
Reduced prefrontal gyrification in obsessive-compulsive disorder.
European archives of psychiatry and clinical neuroscience 2010;260(6):455-64.
2010: Friederike Rampacher; Leonhard Lennertz; Andrea Vogeley; Svenja Schulze-Rauschenbach; Norbert Kathmann; Peter Falkai; Michael Wagner
Evidence for specific cognitive deficits in visual information processing in patients with OCD compared to patients with unipolar depression.
Progress in neuro-psychopharmacology & biological psychiatry 2010;34(6):984-91.
2010: Peter Falkai; Hans-Jürgen Möller
Affective disorders: the role of the duration of untreated illness, suicidality and pharmacogenetics.
European archives of psychiatry and clinical neuroscience 2010;260(5):365-6.
2010: Daniel Martins-de-Souza; Thomas Wobrock; Inga Zerr; Andrea Schmitt; Joanna Gawinecka; Thomas Schneider-Axmann; Peter Falkai; Christoph W Turck
Different apolipoprotein E, apolipoprotein A1 and prostaglandin-H2 D-isomerase levels in cerebrospinal fluid of schizophrenia patients and healthy controls.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2010;11(5):719-28.
2010: C Wolff-Menzler; A Hasan; B Malchow; Peter Falkai; Thomas Wobrock
Combination therapy in the treatment of schizophrenia.
Pharmacopsychiatry 2010;43(4):122-9.
2010: Piotr Lewczuk; Johannes Kornhuber; E Vanmechelen; O Peters; Isabella Heuser; Wolfgang Maier; Frank Jessen; K Bürger; Harald Hampel; Lutz Frölich; F Henn; Peter Falkai; Eckart Rüther; H Jahn; Ch Luckhaus; R Perneczky; Klaus Schmidtke; J Schröder; H Kessler; J Pantel; Hermann-Josef Gertz; hugo Marcel vanderstichele; Geert De Meyer; F Shapiro; S Wolf; Mirko Bibl; J Wiltfang
Amyloid beta peptides in plasma in early diagnosis of Alzheimer's disease: A multicenter study with multiplexing.
Experimental neurology 2010;223(2):366-70.
2010: Juliana Usher; Stefan Leucht; Peter Falkai; Harald Scherk
Correlation between amygdala volume and age in bipolar disorder - a systematic review and meta-analysis of structural MRI studies.
Psychiatry research 2010;182(1):1-8.
2010: Alkomiet Hasan; Aribert Rothenberger; Alexander Münchau; Thomas Wobrock; Peter Falkai; Veit Roessner
Oral delta 9-tetrahydrocannabinol improved refractory Gilles de la Tourette syndrome in an adolescent by increasing intracortical inhibition: a case report.
Journal of clinical psychopharmacology 2010;30(2):190-2.
2010: Borwin Bandelow; Christian Schmahl; Peter Falkai; Dirk Wedekind
Borderline personality disorder: a dysregulation of the endogenous opioid system?
Psychological review 2010;117(2):623-36.
2010: Vilte E Barakauskas; Clare Louise Beasley; Alasdair M Barr; Athena R Ypsilanti; Hong-Ying Li; Allen Thornton; Hubert Wong; Gorazd Rosokilja; J John Mann; Branislav Mancevski; Zlatko Jakovski; Natasha Davceva; Boro Ilievski; Andrew J Dwork; Peter Falkai; William Honer
A novel mechanism and treatment target for presynaptic abnormalities in specific striatal regions in schizophrenia.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2010;35(5):1226-38.
2010: Ilona Henseler; Peter Falkai; Oliver Gruber
Disturbed functional connectivity within brain networks subserving domain-specific subcomponents of working memory in schizophrenia: relation to performance and clinical symptoms.
Journal of psychiatric research 2010;44(6):364-72.
2010: Rainald Mössner; Anna Schuhmacher; Michael Wagner; Boris B Quednow; Ingo Frommann; Kai-Uwe Kühn; Sibylle G Schwab; Marcella Rietschel; Peter Falkai; Wolfgang Wölwer; Stephan Ruhrmann; Andreas Bechdolf; Wolfgang Gaebel; Joachim Klosterkötter; Wolfgang Maier
DAOA/G72 predicts the progression of prodromal syndromes to first episode psychosis.
European archives of psychiatry and clinical neuroscience 2010;260(3):209-15.
2010: Alkomiet Hasan; Peter Falkai; Thomas Wobrock
[Early detection and treatment of schizophrenia].
MMW Fortschritte der Medizin 2010;152(9):53-5.
2010: Eleni Parlapani; Andrea Schmitt; Oliver Wirths; Manfred Bauer; Clemens Sommer; Udo Rueb; Markus H Skowronek; Jens Treutlein; Georg A Petroianu; Marcella Rietschel; Peter Falkai
Gene expression of neuregulin-1 isoforms in different brain regions of elderly schizophrenia patients.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2010;11(2 Pt 2):243-50.
2010: Peter Falkai
What was new, interesting and frequently cited in 2009?
European archives of psychiatry and clinical neuroscience 2010;260(2):87-9.
2010: Daniel Martins-de-Souza; Emmanuel Dias-Neto; Andrea Schmitt; Peter Falkai; Philipp Gormanns; Giuseppina Maccarrone; Christoph W Turck; Wagner F Gattaz
Proteome analysis of schizophrenia brain tissue.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2010;11(2):110-20.
2010: Andrea Schmitt; Jiri Koschel; Mathias Zink; Manfred Bauer; Clemens Sommer; Josef Frank; Jens Treutlein; Thomas G. Schulze; Thomas Schneider-Axmann; Eleni Parlapani; Marcella Rietschel; Peter Falkai; Fritz A Henn
Gene expression of NMDA receptor subunits in the cerebellum of elderly patients with schizophrenia.
European archives of psychiatry and clinical neuroscience 2010;260(2):101-11.
2010: Borwin Bandelow; Kristina Saleh; J Pauls; Katharina Domschke; Dirk Wedekind; Peter Falkai
Insertion/deletion polymorphism in the gene for angiotensin converting enzyme (ACE) in panic disorder: A gender-specific effect?
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2010;11(1):66-70.
2010: Frank-Gerald Pajonk; Thomas Wobrock; Oliver Gruber; Harald Scherk; Dorothea Berner; Inge Kaizl; Astrid Kierer; Stephanie Müller; Martin Oest; Tim Meyer; Martin Backens; Thomas Schneider-Axmann; Allen Thornton; William Honer; Peter Falkai
Hippocampal plasticity in response to exercise in schizophrenia.
Archives of general psychiatry 2010;67(2):133-43.
2010: Thomas Wobrock; Alkomiet Hasan; Berend Malchow; Claus Wolff-Menzler; Birgit Guse; Nicolas Lang; Thomas Schneider-Axmann; Ullrich K H Ecker; Peter Falkai
Increased cortical inhibition deficits in first-episode schizophrenia with comorbid cannabis abuse.
Psychopharmacology 2010;208(3):353-63.
2010: J Usher; P Menzel; Thomas Schneider-Axmann; C Kemmer; W Reith; Peter Falkai; Oliver Gruber; Harald Scherk
Increased right amygdala volume in lithium-treated patients with bipolar I disorder.
Acta psychiatrica Scandinavica 2010;121(2):119-24.
2010: Richard Delorme; Daniel Moreno-De-Luca; Aurélie Gennetier; Wolfgang Maier; Pauline Chaste; Rainald Mössner; Hans Jörgen Grabe; Stephan Ruhrmann; Peter Falkai; Marie-Christine Mouren; Marion Leboyer; Michael Wagner; Catalina Betancur
Search for copy number variants in chromosomes 15q11-q13 and 22q11.2 in obsessive compulsive disorder.
BMC medical genetics 2010;11():100.
2010: Birgit Guse; Peter Falkai; Thomas Wobrock
Cognitive effects of high-frequency repetitive transcranial magnetic stimulation: a systematic review.
Journal of neural transmission (Vienna, Austria : 1996) 2010;117(1):105-22.
2010: Oliver Gruber; Heike Tost; Ilona Henseler; Christine Schmael; Harald Scherk; Gabriele Ende; Matthias Ruf; Peter Falkai; Marcella Rietschel
Pathological amygdala activation during working memory performance: Evidence for a pathophysiological trait marker in bipolar affective disorder.
Human brain mapping 2010;31(1):115-25.
2009: Eleni Parlapani; Andrea Schmitt; Andrea Erdmann; Hans-Gert Bernstein; Barbara Breunig; Oliver Gruber; Georg Petroianu; Martina Von Wilmsdorff; Thomas Schneider-Axmann; William Honer; Peter Falkai
Association between myelin basic protein expression and left entorhinal cortex pre-alpha cell layer disorganization in schizophrenia.
Brain research 2009;1301():126-34.
2009: Anja Schneider; Alkomiet Hasan; Sina Hirschel; Christian Wilhelm; Jürgen Kohlhase; Peter Falkai; Jutta Gärtner; Robert Steinfeld; Thomas Wobrock; Detlef Degner
A novel mutation of the arylsulfatase A gene in late-onset metachromatic leukodystrophy.
The Journal of clinical psychiatry 2009;70(12):1724-5.
2009: Gregor Habl; Mathias Zink; Georg Petroianu; Manfred Bauer; Thomas Schneider-Axmann; Martina Von Wilmsdorff; Peter Falkai; Fritz A Henn; Andrea Schmitt
Increased D-amino acid oxidase expression in the bilateral hippocampal CA4 of schizophrenic patients: a post-mortem study.
Journal of neural transmission (Vienna, Austria : 1996) 2009;116(12):1657-65.
2009: Thomas Wobrock; S Weinmann; Peter Falkai; Wolfgang Gaebel
Quality assurance in psychiatry: quality indicators and guideline implementation.
European archives of psychiatry and clinical neuroscience 2009;259 Suppl 2():S219-26.
2009: Joachim Cordes; Peter Falkai; B Guse; A Hasan; T Schneider-Axmann; M Arends; Georg Winterer; Wolfgang Wölwer; E Ben Sliman; M Ramacher; C Schmidt-Kraepelin; Christian Ohmann; B Langguth; Michael Landgrebe; P Eichhammer; E Frank; J Burger; G Hajak; M Rietschel; T Wobrock
Repetitive transcranial magnetic stimulation for the treatment of negative symptoms in residual schizophrenia: rationale and design of a sham-controlled, randomized multicenter study.
European archives of psychiatry and clinical neuroscience 2009;259 Suppl 2():S189-97.
2009: Esther Kristina Diekhof; Peter Falkai; Oliver Gruber
Functional interactions guiding adaptive processing of behavioral significance.
Human brain mapping 2009;30(10):3325-31.
2009: Thomas Wobrock; Thomas Schneider-Axmann; W Retz; M Rösler; D Kadovic; Peter Falkai; M Schneider
Motor circuit abnormalities in first-episode schizophrenia assessed with transcranial magnetic stimulation.
Pharmacopsychiatry 2009;42(5):194-201.
2009: Edna Grünblatt; Camelia-Maria Monoranu; Manuela Apfelbacher; Daniela Keller; Tanja M Michel; Irina Alafuzoff; Isidro Ferrer; Safa Al-Saraj; Kathy Keyvani; Andrea Schmitt; Peter Falkai; Jens Schittenhelm; Catriona McLean; Glenda M Halliday; Clive Harper; Jürgen Deckert; Wolfgang Roggendorf; Peter Riederer
Tryptophan is a marker of human postmortem brain tissue quality.
Journal of neurochemistry 2009;110(5):1400-8.
2009: David Zilles; Sarah Burke; Thomas Schneider-Axmann; Peter Falkai; Oliver Gruber
Diagnosis-specific effect of familial loading on verbal working memory in schizophrenia.
European archives of psychiatry and clinical neuroscience 2009;259(6):309-15.
2009: I Henseler; Peter Falkai; Oliver Gruber
A systematic fMRI investigation of the brain systems subserving different working memory components in schizophrenia.
The European journal of neuroscience 2009;30(4):693-702.
2009: Thomas Wobrock; J Köhler; P Klein; Peter Falkai
Achieving symptomatic remission in out-patients with schizophrenia--a naturalistic study with quetiapine.
Acta psychiatrica Scandinavica 2009;120(2):120-8.
2009: Thomas Wobrock; Oliver Gruber; Thomas Schneider-Axmann; Wolfgang Wölwer; Wolfgang Gaebel; Mathias Riesbeck; Wolfgang Maier; Joachim Klosterkötter; Frank Schneider; Gerhard Buchkremer; Hans-Jürgen Möller; Andrea Schmitt; Stefan Bender; Ralf Schlösser; Peter Falkai
Internal capsule size associated with outcome in first-episode schizophrenia.
European archives of psychiatry and clinical neuroscience 2009;259(5):278-83.
2009: Guy Goodwin; Wolfgang Fleischhacker; Celso Arango; Pierre Baumann; Michael Davidson; marc de hert; Peter Falkai; Shitij Kapur; Stefan Leucht; Rasmus Licht; Dieter Naber; Veronica O'Keane; George Papakostas; Eduard Vieta; Joseph Zohar
Advantages and disadvantages of combination treatment with antipsychotics ECNP Consensus Meeting, March 2008, Nice.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2009;19(7):520-32.
2009: Camelia-Maria Monoranu; M Apfelbacher; Edna Grünblatt; Bernhard Puppe; Irina Alafuzoff; I Ferrer; S Al-Saraj; K Keyvani; Angelika Schmitt; Peter Falkai; J Schittenhelm; Glenda M Halliday; J Kril; C Harper; C McLean; Peter Riederer; Wolfgang Roggendorf
pH measurement as quality control on human post mortem brain tissue: a study of the BrainNet Europe consortium.
Neuropathology and applied neurobiology 2009;35(3):329-37.
2009: Harald Scherk; Oliver Gruber; Patrick Menzel; Thomas Schneider-Axmann; Claudia Kemmer; Juliana Usher; Wolfgang Reith; Jobst Meyer; Peter Falkai
5-HTTLPR genotype influences amygdala volume.
European archives of psychiatry and clinical neuroscience 2009;259(4):212-7.
2009: K Jamrozinski; Oliver Gruber; C Kemmer; Peter Falkai; Harald Scherk
Neurocognitive functions in euthymic bipolar patients.
Acta psychiatrica Scandinavica 2009;119(5):365-74.
2009: Daniel Martins-de-Souza; Giuseppina Maccarrone; Stefan Reckow; Peter Falkai; Andrea Schmitt; Christoph W Turck
Shotgun mass spectrometry analysis of the human thalamus proteome.
Journal of separation science 2009;32(8):1231-6.
2009: Thomas Wobrock; Peter Falkai; Thomas Schneider-Axmann; Nicole Frommann; Wolfgang Wölwer; Wolfgang Gaebel
Effects of abstinence on brain morphology in alcoholism: a MRI study.
European archives of psychiatry and clinical neuroscience 2009;259(3):143-50.
2009: Oliver Gruber; Tobias Melcher; Esther K Diekhof; Susanne Karch; Peter Falkai; Thomas Goschke
Brain mechanisms associated with background monitoring of the environment for potentially significant sensory events.
Brain and cognition 2009;69(3):559-64.
2009: Andrea Schmitt; Corinna Steyskal; Hans-Gert Bernstein; Thomas Schneider-Axmann; Eleni Parlapani; Evelin L Schaeffer; Wagner F Gattaz; Bernhard Bogerts; Christoph Schmitz; Peter Falkai
Stereologic investigation of the posterior part of the hippocampus in schizophrenia.
Acta neuropathologica 2009;117(4):395-407.
2009: Thomas Wobrock; Helmut Sittinger; Bernd Behrendt; Roberto D'Amelio; Peter Falkai
Comorbid substance abuse and brain morphology in recent-onset psychosis.
European archives of psychiatry and clinical neuroscience 2009;259(1):28-36.
2009: Thomas Wobrock; Ulrike Mihm; Caroline Löhr; Wolf-Peter Hofmann; Christoph Sarrazin; Stefan Zeuzem; Peter Falkai
Cognition in hepatitis C patients treated with pegylated interferon.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2009;10(4 Pt 3):819-26.
2009: Harald Scherk; Martin Backens; Thomas Schneider-Axmann; Juliana Usher; Claudia Kemmer; Wolfgang Reith; Peter Falkai; Oliver Gruber
Cortical neurochemistry in euthymic patients with bipolar I disorder.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2009;10(4):285-94.
2009: Deborah Janowitz; Hans Joergen Grabe; Stephan Ruhrmann; Susan Ettelt; Friederike Buhtz; Andrea Hochrein; Svenja Schulze-Rauschenbach; Klaus Meyer; Susanne Kraft; Claudia Ferber; Ralf Pukrop; Harald J Freyberger; Joachim Klosterkötter; Peter Falkai; Ulrich John; Wolfgang Maier; Michael Wagner
Early onset of obsessive-compulsive disorder and associated comorbidity.
Depression and anxiety 2009;26(11):1012-7.
2009: Gerald Stober; Dorit Ben-Shachar; M Cardon; Peter Falkai; Alfred Fonteh; Micha Gawlik; Birte Y Glenthoj; Edna Grunblatt; Assen Jablensky; Yong-Ku Kim; Johannes Kornhuber; Thomas F McNeil; Norbert Muller; Bob Oranje; Toshikazu Saito; Mohamed SAOUD; Andrea Schmitt; Michal Schwartz; Johannes Thome; Marat Uzbekov; Nuria Durany; Peter Riederer
Schizophrenia: from the brain to peripheral markers. A consensus paper of the WFSBP task force on biological markers.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2009;10(2):127-55.
2009: Oliver Gruber; Peter Falkai
[From identification of neurofunctional systems to individualization of treatment for schizophrenic disorders].
Der Nervenarzt 2009;80(1):12, 14, 16-8 passim.
2009: Thomas Wobrock; Ullrich K H Ecker; Harald Scherk; Thomas Schneider-Axmann; Peter Falkai; Oliver Gruber
Cognitive impairment of executive function as a core symptom of schizophrenia.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2009;10(4 Pt 2):442-51.
2009: Harald Scherk; Martin Backens; Thomas Schneider-Axmann; Susanne Kraft; Claudia Kemmer; Juliana Usher; Wolfgang Reith; Peter Falkai; Jobst Meyer; Oliver Gruber
Dopamine transporter genotype influences N-acetyl-aspartate in the left putamen.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2009;10(4 Pt 2):524-30.
2008: Holger Kessler; Frank-Gerald Pajonk; Daniela Bach; Thomas Schneider-Axmann; Peter Falkai; Wolfgang Herrmann; Gerd Multhaup; Jens Wiltfang; Stephanie Schäfer; Oliver Wirths; Thomas A Bayer
Effect of copper intake on CSF parameters in patients with mild Alzheimer's disease: a pilot phase 2 clinical trial.
Journal of neural transmission (Vienna, Austria : 1996) 2008;115(12):1651-9.
2008: Andrea Schmitt; Eleni Parlapani; Oliver Gruber; Thomas Wobrock; Peter Falkai
Impact of neuregulin-1 on the pathophysiology of schizophrenia in human post-mortem studies.
European archives of psychiatry and clinical neuroscience 2008;258 Suppl 5():35-9.
2008: Harald Scherk; Martin Backens; Peter Zill; Thomas Schneider-Axmann; Thomas Wobrock; Juliana Usher; Wolfgang Reith; Peter Falkai; Hans-Jürgen Möller; Brigitta Bondy; Oliver Gruber
SNAP-25 genotype influences NAA/Cho in left hippocampus.
Journal of neural transmission (Vienna, Austria : 1996) 2008;115(11):1513-8.
2008: Esther Kristina Diekhof; Peter Falkai; Oliver Gruber
Functional neuroimaging of reward processing and decision-making: a review of aberrant motivational and affective processing in addiction and mood disorders.
Brain research reviews 2008;59(1):164-84.
2008: Tobias Melcher; Peter Falkai; Oliver Gruber
Functional brain abnormalities in psychiatric disorders: neural mechanisms to detect and resolve cognitive conflict and interference.
Brain research reviews 2008;59(1):96-124.
2008: Oliver Gruber; Peter Falkai; Thomas Schneider-Axmann; Sibylle G Schwab; Michael Wagner; Wolfgang Maier
Neuregulin-1 haplotype HAP(ICE) is associated with lower hippocampal volumes in schizophrenic patients and in non-affected family members.
Journal of psychiatric research 2008;43(1):1-6.
2008: Thorsten Pfuhl; Alfredo Mamiani; Matthias Dürr; Susanne Welter; Johanna Stieber; Jasmin Ankara; Michael Liss; Thomas Dobner; Andrea Schmitt; Peter Falkai; Elisabeth Kremmer; Volker Jung; Stephanie Barth; Friedrich A Grässer
The LARK/RBM4a protein is highly expressed in cerebellum as compared to cerebrum.
Neuroscience letters 2008;444(1):11-5.
2008: T Wobrock; M Schneider; D Kadovic; Thomas Schneider-Axmann; U K H Ecker; W Retz; M Rösler; Peter Falkai
Reduced cortical inhibition in first-episode schizophrenia.
Schizophrenia research 2008;105(1-3):252-61.
2008: Florian Ebner; Ralf Tepest; Indra Dani; Ute Pfeiffer; Thomas G. Schulze; Marcella Rietschel; Wolfgang Maier; Frank Träber; Wolfgang Block; Hans H Schild; Michael Wagner; Helmuth Steinmetz; Wolfgang Gaebel; William Honer; Thomas Schneider-Axmann; Peter Falkai
The hippocampus in families with schizophrenia in relation to obstetric complications.
Schizophrenia research 2008;104(1-3):71-8.
2008: Martin Begemann; Derya Sargin; Moritz Rossner; Claudia Bartels; Fabian Theis; Sven P Wichert; Nike Stender; Benjamin Fischer; Swetlana Sperling; Sabina Stawicki; Anne Wiedl; Peter Falkai; Klaus-Armin Nave; Hannelore Ehrenreich
Episode-specific differential gene expression of peripheral blood mononuclear cells in rapid cycling supports novel treatment approaches.
Molecular medicine (Cambridge, Mass.) 2008;14(9-10):546-52.
2008: Harald Scherk; Claudia Kemmer; Juliana Usher; Wolfgang Reith; Peter Falkai; Oliver Gruber
No change to grey and white matter volumes in bipolar I disorder patients.
European archives of psychiatry and clinical neuroscience 2008;258(6):345-9.
2008: Holger Kessler; Thomas A Bayer; Daniela Bach; Thomas Schneider-Axmann; Tillmann Supprian; Wolfgang Herrmann; Manfred Haber; Gerd Multhaup; Peter Falkai; Frank-Gerald Pajonk
Intake of copper has no effect on cognition in patients with mild Alzheimer's disease: a pilot phase 2 clinical trial.
Journal of neural transmission (Vienna, Austria : 1996) 2008;115(8):1181-7.
2008: Peter Falkai
Limitations of current therapies: why do patients switch therapies?
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2008;18 Suppl 3():S135-9.
2008: Ralf Tepest; Kai Vogeley; Bettina Viebahn; Thomas Schneider-Axmann; William Honer; Peter Falkai
Automated gray level index measurements reveal only minor cytoarchitectonic changes of Brodmann area 9 in schizophrenia.
Psychiatry research 2008;163(2):183-92.
2008: Peter Falkai; Owen Mike; Myin-Germeys Inez; Harrison Paul; Bilkei-Gorzo Andras; Frangou Sophia
A roadmap to disentangle the molecular etiology of schizophrenia.
European psychiatry : the journal of the Association of European Psychiatrists 2008;23(4):224-32.
2008: René Hurlemann; Frank Jessen; Michael Wagner; I Frommann; S Ruhrmann; Anke Brockhaus-Dumke; H Picker; Lukas Scheef; W Block; Hans H Schild; W Moller-Hartmann; B Krug; Peter Falkai; J Klosterkotter; Wolfgang Maier
Interrelated neuropsychological and anatomical evidence of hippocampal pathology in the at-risk mental state.
Psychological medicine 2008;38(6):843-51.
2008: Oliver Gruber; Peter Falkai
[Treatment of schizophrenia: what the family doctor should know].
MMW Fortschritte der Medizin 2008;150 Suppl 2():16-9; quiz 20.
2008: Ilona Henseler; Oliver Gruber; Susanne Kraft; Christoph Krick; Wolfgang Reith; Peter Falkai
Compensatory hyperactivations as markers of latent working memory dysfunctions in patients with obsessive-compulsive disorder: an fMRI study.
Journal of psychiatry & neuroscience : JPN 2008;33(3):209-15.
2008: Peter Falkai; T Wobrock; Thomas Schneider-Axmann; Oliver Gruber
[Schizophrenia as a brain disorder and its development].
Fortschritte der Neurologie-Psychiatrie 2008;76 Suppl 1():S63-7.
2008: Jeanne E Bell; Irina Alafuzoff; Safa Al-Sarraj; Thomas Arzberger; Nenad Bogdanovic; Herbert Budka; David T Dexter; Peter Falkai; Isidro Ferrer; Ellen Gelpi; Stephen M Gentleman; Giorgio Giaccone; Inge Huitinga; James W Ironside; Natasja Klioueva; Gabor Geza Kovacs; David Meyronet; Miklós Palkovits; Piero Parchi; Efstatios Patsouris; Richard Reynolds; Peter Riederer; Wolfgang Roggendorf; Danielle Seilhean; Andrea Schmitt; Peer Schmitz; Nathalie Streichenberger; Ameli Schwalber; Hans A Kretzschmar
Management of a twenty-first century brain bank: experience in the BrainNet Europe consortium.
Acta neuropathologica 2008;115(5):497-507.
2008: Andrea Schmitt; Eleni Parlapani; Manfred Bauer; Helmut Heinsen; Peter Falkai
Is brain banking of psychiatric cases valuable for neurobiological research?
Clinics (São Paulo, Brazil) 2008;63(2):255-66.
2008: Andrea Pfennig; Beate Weikert; Peter Falkai; Thomas Gotz; Ina Kopp; Johanna Sasse; Harald Scherk; Daniel Strech; Michael Bauer
[Development of the evidence-based S3 guideline for diagnosis and therapy of bipolar disorders].
Der Nervenarzt 2008;79(4):500-4.
2008: Harald Scherk; M Backens; Thomas Schneider-Axmann; C Kemmer; J Usher; W Reith; Peter Falkai; Oliver Gruber
Neurochemical pathology in hippocampus in euthymic patients with bipolar I disorder.
Acta psychiatrica Scandinavica 2008;117(4):283-8.
2008: Susan Ettelt; Hans Joergen Grabe; Stephan Ruhrmann; Friederike Buhtz; Andrea Hochrein; Susanne Kraft; Ralf Pukrop; Joachim Klosterkötter; Peter Falkai; Wolfgang Maier; Ulrich John; Harald J Freyberger; Michael Wagner
Harm avoidance in subjects with obsessive-compulsive disorder and their families.
Journal of affective disorders 2008;107(1-3):265-9.
2008: Peter Falkai
[Gambler--porn addict--computer freak. Were is the borderline to illness?].
MMW Fortschritte der Medizin 2008;150(11):28.
2008: Oliver Gruber; E K Diekhof; Peter Falkai
[Functional organisation of frontal cortex].
Fortschritte der Neurologie-Psychiatrie 2008;76(3):174-80.
2008: Daniel J Strauss; Wolfgang Delb; Robert D'Amelio; Yin Fen Low; Peter Falkai
Objective quantification of the tinnitus decompensation by synchronization measures of auditory evoked single sweeps.
IEEE transactions on neural systems and rehabilitation engineering : a publication of the IEEE Engineering in Medicine and Biology Society 2008;16(1):74-81.
2008: Mirko Bibl; Brit Mollenhauer; Hermann Esselmann; Michael Schneider; Piotr Lewczuk; Volker Welge; Martin Gross; Peter Falkai; Johannes Kornhuber; Jens Wiltfang
Cerebrospinal fluid neurochemical phenotypes in vascular dementias: original data and mini-review.
Dementia and geriatric cognitive disorders 2008;25(3):256-65.
2008: Hans Joergen Grabe; Stephan Ruhrmann; Carsten Spitzer; Jana Josepeit; Susan Ettelt; Friederike Buhtz; Andrea Hochrein; Svenja Schulze-Rauschenbach; Klaus Meyer; Susanne Kraft; Claudia Reck; Ralf Pukrop; Joachim Klosterkötter; Peter Falkai; Wolfgang Maier; Michael Wagner; Ulrich John; Harald J Freyberger
Obsessive-compulsive disorder and posttraumatic stress disorder.
Psychopathology 2008;41(2):129-34.
2008: T Wobrock; R D'Amelio; Peter Falkai
[Pharmacotherapy of schizophrenia and comorbid substance use disorder. A systematic review].
Der Nervenarzt 2008;79(1):17-8, 20-2, 24-6 passim.
2008: Thomas Wobrock; Thomas Kamer; Anand Roy; Kai Vogeley; Thomas Schneider-Axmann; Michael Wagner; Wolfgang Maier; Marcella Rietschel; Thomas G. Schulze; Harald Scherk; Hans H Schild; Wolfgang Block; Frank Träber; Ralf Tepest; William Honer; Peter Falkai
Reduction of the internal capsule in families affected with schizophrenia.
Biological psychiatry 2008;63(1):65-71.
2007: H Kessler; Tillmann Supprian; Peter Falkai
[Pharmacological treatment options in frontotemporal dementia].
Fortschritte der Neurologie-Psychiatrie 2007;75(12):714-9.
2007: Wolfgang Gaebel; Mathias Riesbeck; Wolfgang Wölwer; Ansgar Klimke; Matthias Eickhoff; Martina Von Wilmsdorff; Maria C Jockers-Scherübl; Kai-Uwe Kühn; Matthias Lemke; Andreas Bechdolf; Stefan Bender; Detlef Degner; Ralf Schlösser; Lutz G Schmidt; Andrea Schmitt; Markus Jäger; Gerhard Buchkremer; Peter Falkai; Stefan Klingberg; Wolfgang Köpcke; Wolfgang Maier; Heinz Häfner; Christian Ohmann; Hans Joachim Salize; Frank Schneider; Hans-Jürgen Möller
Maintenance treatment with risperidone or low-dose haloperidol in first-episode schizophrenia: 1-year results of a randomized controlled trial within the German Research Network on Schizophrenia.
The Journal of clinical psychiatry 2007;68(11):1763-74.
2007: Peter Falkai; William Honer; Thomas Kamer; Simone Dustert; Kai Vogeley; Thomas Schneider-Axmann; Indra Dani; Michael Wagner; Marcella Rietschel; Daniel J Müller; Thomas G. Schulze; Wolfgang Gaebel; Joachim Cordes; Helmut Schönell; Hans H Schild; Wolfgang Block; Frank Träber; Helmuth Steinmetz; Wolfgang Maier; Ralf Tepest
Disturbed frontal gyrification within families affected with schizophrenia.
Journal of psychiatric research 2007;41(10):805-13.
2007: Frank Schneider; Ute Habel; Martina Reske; Ivan Toni; Peter Falkai; N Jon Shah
Neural substrates of olfactory processing in schizophrenia patients and their healthy relatives.
Psychiatry research 2007;155(2):103-12.
2007: Thomas Wobrock; D Kadovic; Peter Falkai
[Cortical excitability in schizophrenia. Studies using transcranial magnetic stimulation].
Der Nervenarzt 2007;78(7):753-4, 756-63.
2007: Oliver Wirths; Karin M Thelen; Dieter Lütjohann; Peter Falkai; Thomas A Bayer
Altered cholesterol metabolism in APP695-transfected neuroblastoma cells.
Brain research 2007;1152():209-14.
2007: Thomas Wobrock; Helmut Sittinger; Bernd Behrendt; Roberto D'Amelio; Peter Falkai; Dieter Caspari
Comorbid substance abuse and neurocognitive function in recent-onset schizophrenia.
European archives of psychiatry and clinical neuroscience 2007;257(4):203-10.
2007: Urban W Geisthoff; Katinka Heckmann; Roberto D'Amelio; Stefan Grünewald; Dirk Knöbber; Peter Falkai; Jochem König
Health-related quality of life in hereditary hemorrhagic telangiectasia.
Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 2007;136(5):726-33; discussion 734-5.
2007: Andrea Schmitt; Markus Fendt; Mathias Zink; U Ebert; M Starke; M Berthold; A Herb; Georg A Petroianu; Peter Falkai; Fritz A Henn
Altered NMDA receptor expression and behavior following postnatal hypoxia: potential relevance to schizophrenia.
Journal of neural transmission (Vienna, Austria : 1996) 2007;114(2):239-48.
2007: Iris Bertram; Hans-Gert Bernstein; Uwe Lendeckel; Alicja Bukowska; Henrik Dobrowolny; Gerburg Keilhoff; Dimitrios N. Kanakis; Christian Mawrin; Hendrik Bielau; Peter Falkai; Bernhard Bogerts
Immunohistochemical evidence for impaired neuregulin-1 signaling in the prefrontal cortex in schizophrenia and in unipolar depression.
Annals of the New York Academy of Sciences 2007;1096():147-56.
2007: Oliver Gruber; T Müller; Peter Falkai
Dynamic interactions between neural systems underlying different components of verbal working memory.
Journal of neural transmission (Vienna, Austria : 1996) 2007;114(8):1047-50.
2007: Susan Ettelt; Stephan Ruhrmann; Sven Barnow; F Buthz; Andrea Hochrein; Klaus Meyer; Susanne Kraft; Claudia Reck; Ralf Pukrop; Joachim Klosterkötter; Peter Falkai; Wolfgang Maier; Michael Wagner; Harald J Freyberger; Hans Joergen Grabe
Impulsiveness in obsessive-compulsive disorder: results from a family study.
Acta psychiatrica Scandinavica 2007;115(1):41-7.
2007: A Schmitt; Martin Bauer; Helmut Heinsen; W Feiden; Peter Falkai; Irina Alafuzoff; Thomas Arzberger; Safa Al-Sarraj; J E Bell; Nenad Bogdanovic; W Brück; Herbert Budka; Isidro Ferrer; Giorgio Giaccone; Gabor Geza Kovacs; David Meyronet; Miklós Palkovits; Piero Parchi; Efstratios Patsouris; Rivka Ravid; R Reynolds; Peter Riederer; Wolfgang Roggendorf; Ameli Schwalber; Danielle Seilhean; Hans A Kretzschmar
How a neuropsychiatric brain bank should be run: a consensus paper of Brainnet Europe II.
Journal of neural transmission (Vienna, Austria : 1996) 2007;114(5):527-37.
2006: Hans Joergen Grabe; Stephan Ruhrmann; Susan Ettelt; Friederike Buhtz; Andrea Hochrein; Svenja Schulze-Rauschenbach; Klaus Meyer; Susanne Kraft; Claudia Reck; Ralf Pukrop; Harald J Freyberger; Joachim Klosterkötter; Peter Falkai; Ulrich John; Wolfgang Maier; Michael Wagner
Familiality of obsessive-compulsive disorder in nonclinical and clinical subjects.
The American journal of psychiatry 2006;163(11):1986-92.
2006: H Kessler; Frank-Gerald Pajonk; P Meisser; Thomas Schneider-Axmann; K-H Hoffmann; Tillmann Supprian; W Herrmann; R Obeid; Gerd Multhaup; Peter Falkai; Thomas A Bayer
Cerebrospinal fluid diagnostic markers correlate with lower plasma copper and ceruloplasmin in patients with Alzheimer's disease.
Journal of neural transmission (Vienna, Austria : 1996) 2006;113(11):1763-9.
2006: Frank Jessen; Harald Scherk; Frank Träber; Sonja Theyson; Julia Berning; Ralf Tepest; Peter Falkai; Hans H Schild; Wolfgang Maier; Michael Wagner; Wolfgang Block
Proton magnetic resonance spectroscopy in subjects at risk for schizophrenia.
Schizophrenia research 2006;87(1-3):81-8.
2006: Thomas Schneider-Axmann; Thomas Kamer; Manuel Moroni; Nadja Maric; Ralf Tepest; Indra Dani; William Honer; Harald Scherk; Marcella Rietschel; Thomas G. Schulze; Daniel J Müller; Joachim Cordes; Helmut Schönell; Helmuth Steinmetz; Wolfgang Gaebel; Kai Vogeley; Kai-Uwe Kühn; Michael Wagner; Wolfgang Maier; Frank Träber; Wolfgang Block; Hans H Schild; Peter Falkai
Relation between cerebrospinal fluid, gray matter and white matter changes in families with schizophrenia.
Journal of psychiatric research 2006;40(7):646-55.
2006: Oliver Gruber; Eva Gruber; Peter Falkai
Articulatory rehearsal in verbal working memory: a possible neurocognitive endophenotype that differentiates between schizophrenia and schizoaffective disorder.
Neuroscience letters 2006;405(1-2):24-8.
2006: Michael Rösler; Wolfgang Retz; Johannes Thome; M Schneider; R-D Stieglitz; Peter Falkai
Psychopathological rating scales for diagnostic use in adults with attention-deficit/hyperactivity disorder (ADHD).
European archives of psychiatry and clinical neuroscience 2006;256 Suppl 1():i3-11.
2006: Karin M Thelen; Peter Falkai; Thomas A Bayer; Dieter Lütjohann
Cholesterol synthesis rate in human hippocampus declines with aging.
Neuroscience letters 2006;403(1-2):15-9.
2006: Oliver Gruber; S Karch; E K Schlueter; Peter Falkai; Thomas Goschke
Neural mechanisms of advance preparation in task switching.
NeuroImage 2006;31(2):887-95.
2006: Harald Scherk; Peter Falkai
Effects of antipsychotics on brain structure.
Current opinion in psychiatry 2006;19(2):145-50.
2006: William Honer; Allen Thornton; Eric Yu Hai Chen; Raymond C K Chan; Jessica O Y Wong; Andrea Bergmann; Peter Falkai; Edith Pomarol-Clotet; Peter J McKenna; Emmanuel Stip; Richard Williams; G William MacEwan; Kishor M Wasan; Ric M Procyshyn
Clozapine alone versus clozapine and risperidone with refractory schizophrenia.
The New England journal of medicine 2006;354(5):472-82.
2006: Oliver Wirths; Karin M Thelen; Henning Breyhan; Berta Luzón-Toro; Karl-Heinz Hoffmann; Peter Falkai; Dieter Lütjohann; Thomas A Bayer
Decreased plasma cholesterol levels during aging in transgenic mouse models of Alzheimer's disease.
Experimental gerontology 2006;41(2):220-4.
2006: Hans Joergen Grabe; Stephan Ruhrmann; Susan Ettelt; Angela Muller; Friederike Buhtz; Andrea Hochrein; Svenja Schulze-Rauschenbach; Klaus Meyer; Susanne Kraft; Claudia Reck; Ralf Pukrop; Joachim Klosterkotter; Peter Falkai; Wolfgang Maier; Michael Wagner; Ulrich John; Harald J Freyberger
Alexithymia in obsessive-compulsive disorder - results from a family study.
Psychotherapy and psychosomatics 2006;75(5):312-8.
2006: Peter Falkai; Thomas Wobrock; Jeffrey Lieberman; Birte Glenthoj; Wagner F Gattaz; Hans-Jürgen Möller
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 2: long-term treatment of schizophrenia.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2006;7(1):5-40.
2005: Andrea Schmitt; Thomas Bertsch; Uwe Henning; Heike Tost; Ansgar Klimke; Fritz A Henn; Peter Falkai
Increased serum S100B in elderly, chronic schizophrenic patients: negative correlation with deficit symptoms.
Schizophrenia research 2005;80(2-3):305-13.
2005: René Hurlemann; Ralf Tepest; Wolfgang Maier; Peter Falkai; Kai Vogeley
Intact hippocampal gray matter in schizophrenia as revealed by automatized image analysis postmortem.
Anatomy and embryology 2005;210(5-6):513-7.
2005: René Hurlemann; Christian Boy; Philipp T Meyer; Harald Scherk; Michael Wagner; Hans Herzog; Heinz H Coenen; Kai Vogeley; Peter Falkai; Karl Zilles; Wolfgang Maier; Andreas Bauer
Decreased prefrontal 5-HT2A receptor binding in subjects at enhanced risk for schizophrenia.
Anatomy and embryology 2005;210(5-6):519-23.
2005: J Szczygielski; A Mautes; W I Steudel; Peter Falkai; Thomas A Bayer; Oliver Wirths
Traumatic brain injury: cause or risk of Alzheimer's disease? A review of experimental studies.
Journal of neural transmission (Vienna, Austria : 1996) 2005;112(11):1547-64.
2005: Clare Louise Beasley; William Honer; Klaus Bergmann; Peter Falkai; Dieter Lütjohann; Thomas A Bayer
Reductions in cholesterol and synaptic markers in association cortex in mood disorders.
Bipolar disorders 2005;7(5):449-55.
2005: Frank-Gerald Pajonk; Holger Kessler; Tillmann Supprian; Pegah Hamzei; Daniela Bach; Janina Schweickhardt; Wolfgang Herrmann; Rima Obeid; Andreas Simons; Peter Falkai; Gerd Multhaup; Thomas A Bayer
Cognitive decline correlates with low plasma concentrations of copper in patients with mild to moderate Alzheimer's disease.
Journal of Alzheimer's disease : JAD 2005;8(1):23-7.
2005: Andrea Schmitt; Thomas Bertsch; Heike Tost; Andrea Bergmann; Uwe Henning; Ansgar Klimke; Peter Falkai
Increased serum interleukin-1beta and interleukin-6 in elderly, chronic schizophrenic patients on stable antipsychotic medication.
Neuropsychiatric disease and treatment 2005;1(2):171-7.
2005: H Kessler; Frank-Gerald Pajonk; Tillmann Supprian; Peter Falkai; Gerd Multhaup; T A Bayer
[The role of copper in the pathophysiology of Alzheimer's disease].
Der Nervenarzt 2005;76(5):581-5.
2005: Svenja C Schulze-Rauschenbach; Uta Harms; Thomas Schlaepfer; Wolfgang Maier; Peter Falkai; Michael Wagner
Distinctive neurocognitive effects of repetitive transcranial magnetic stimulation and electroconvulsive therapy in major depression.
The British journal of psychiatry : the journal of mental science 2005;186():410-6.
2005: Frank-Gerald Pajonk; Thomas Wobrock; Peter Falkai
[Longterm therapy of schizophrenia].
Fortschritte der Neurologie-Psychiatrie 2005;73(4):218-31; quiz 232-4.
2005: Ken Sawada; Alasdair M Barr; Masato Nakamura; Kunimasa Arima; Clint Young; andrew dwork; Peter Falkai; Anthony G Phillips; William Honer
Hippocampal complexin proteins and cognitive dysfunction in schizophrenia.
Archives of general psychiatry 2005;62(3):263-72.
2005: Frank-Gerald Pajonk; Thomas Wobrock; Peter Falkai
[Longterm therapy of schizophrenia].
Fortschritte der Neurologie-Psychiatrie 2005;73(3):161-74; quiz 175-7.
2005: Oliver Gruber; E Gruber; Peter Falkai
[Neural correlates of working memory deficits in schizophrenic patients. Ways to establish neurocognitive endophenotypes of psychiatric disorders].
Der Radiologe 2005;45(2):153-60.
2005: Thomas Wobrock; Harald Scherk; Peter Falkai
[Magnetic resonance spectroscopy in schizophrenia. Possibilities and limitations].
Der Radiologe 2005;45(2):124-30, 132-6.
2005: Peter Falkai; Thomas Wobrock; Jeffrey Lieberman; Birte Glenthoj; Wagner F Gattaz; Hans-Jürgen Möller
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, Part 1: acute treatment of schizophrenia.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2005;6(3):132-91.
2004: Peter Falkai; Ralf Tepest; William Honer; Indra Dani; Guido Ahle; Ute Pfeiffer; Kai Vogeley; Thomas G. Schulze; Marcella Rietschel; Joachim Cordes; Helmut Schönell; Wolfgang Gaebel; Kai-Uwe Kühn; Wolfgang Maier; Frank Träber; Wolfgang Block; Hans H Schild; Thomas Schneider-Axmann
Shape changes in prefrontal, but not parieto-occipital regions: brains of schizophrenic patients come closer to a circle in coronal and sagittal view.
Psychiatry research 2004;132(3):261-71.
2004: Thomas Wobrock; Peter Falkai; Frank-Gerald Pajonk
[Acute treatment of schizophrenia].
Fortschritte der Neurologie-Psychiatrie 2004;72(12):705-23; quiz 724-6.
2004: Joern Schmaljohann; Martina Minnerop; P Karwath; Daniela Gündisch; Peter Falkai; Stefan Guhlke; Ullrich Wüllner
Imaging of central nAChReceptors with 2-[18F]F-A85380: optimized synthesis and in vitro evaluation in Alzheimer's disease.
Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 2004;61(6):1235-40.
2004: Peter Falkai; Ralf Tepest; Thomas G. Schulze; Daniel J Müller; Marcella Rietschel; Wolfgang Maier; Frank Träber; Wolfgang Block; Hans H Schild; Helmuth Steinmetz; Wolfgang Gaebel; William Honer; Thomas Schneider-Axmann; M Wagner
Etiopathogenetic mechanisms in long-term course of schizophrenia.
Pharmacopsychiatry 2004;37 Suppl 2():S136-40.
2004: Harald Scherk; Peter Falkai
[Changes in brain structure caused by neuroleptic medication].
Der Nervenarzt 2004;75(11):1112-7.
2004: Ute Habel; Martina Klein; N Jon Shah; Ivan Toni; Karl Zilles; Peter Falkai; Frank Schneider
Genetic load on amygdala hypofunction during sadness in nonaffected brothers of schizophrenia patients.
The American journal of psychiatry 2004;161(10):1806-13.
2004: Tillmann Supprian; Werner Reiche; Bernd Schmitz; Iris Quasar Grunwald; Martin Backens; Erich Hofmann; Thomas Georg; Peter Falkai; Wolfgang Reith
MRI of the brainstem in patients with major depression, bipolar affective disorder and normal controls.
Psychiatry research 2004;131(3):269-76.
2004: Harald Scherk; Wolfgang Reith; Peter Falkai
[Changes in brain structure in bipolar affective disorders].
Der Nervenarzt 2004;75(9):861-72.
2004: Kai Vogeley; M May; A Ritzl; Peter Falkai; Karl Zilles; Gereon R Fink
Neural correlates of first-person perspective as one constituent of human self-consciousness.
Journal of cognitive neuroscience 2004;16(5):817-27.
2004: Thomas Wobrock; Frank-Gerald Pajonk; Peter Falkai
[Schizophrenia].
Fortschritte der Neurologie-Psychiatrie 2004;72(3):164-74.
2004: Thomas Wobrock; Frank-Gerald Pajonk; Peter Falkai
[Schizophrenia].
Fortschritte der Neurologie-Psychiatrie 2004;72(2):98-113.
2003: Kai-Uwe Kühn; Boris B Quednow; Markus Thiel; Peter Falkai; Wolfgang Maier; Christian E Elger
Antidepressive treatment in patients with temporal lobe epilepsy and major depression: a prospective study with three different antidepressants.
Epilepsy & behavior : E&B 2003;4(6):674-9.
2003: Ralf Tepest; Lei Wang; Michael I Miller; Peter Falkai; John G Csernansky
Hippocampal deformities in the unaffected siblings of schizophrenia subjects.
Biological psychiatry 2003;54(11):1234-40.
2003: S Kovalenko; A Bergmann; Thomas Schneider-Axmann; I Ovary; K Majtenyi; L Havas; William Honer; B Bogerts; Peter Falkai
Regio entorhinalis in schizophrenia: more evidence for migrational disturbances and suggestions for a new biological hypothesis.
Pharmacopsychiatry 2003;36 Suppl 3():S158-61.
2003: Sean W Flynn; Donna Jane Lang; Alex L MacKay; Vina M Goghari; Irene M Vavasour; Kenneth P Whittall; Geoffrey N Smith; Victoria Arango; J John Mann; andrew dwork; Peter Falkai; William Honer
Abnormalities of myelination in schizophrenia detected in vivo with MRI, and post-mortem with analysis of oligodendrocyte proteins.
Molecular psychiatry 2003;8(9):811-20.
2003: Harald Scherk; Kai Vogeley; Peter Falkai
[The importance of interneurons in schizophrenic and affective disorders].
Fortschritte der Neurologie-Psychiatrie 2003;71 Suppl 1():S27-32.
2003: Kai Vogeley; Ralf Tepest; Thomas Schneider-Axmann; Helge Hütte; Karl Zilles; William Honer; Peter Falkai
Automated image analysis of disturbed cytoarchitecture in Brodmann area 10 in schizophrenia.
Schizophrenia research 2003;62(1-2):133-40.
2003: Peter Falkai; Thomas Schneider-Axmann; William Honer; Kai Vogeley; Helmut Schönell; Ute Pfeiffer; Harald Scherk; Wolfgang Block; Frank Träber; Hans H Schild; Wolfgang Maier; Ralf Tepest
Influence of genetic loading, obstetric complications and premorbid adjustment on brain morphology in schizophrenia: a MRI study.
European archives of psychiatry and clinical neuroscience 2003;253(2):92-9.
2003: Geoffrey N Smith; Donna Jane Lang; Lili C Kopala; Jocelyne S Lapointe; Peter Falkai; William Honer
Developmental abnormalities of the hippocampus in first-episode schizophrenia.
Biological psychiatry 2003;53(7):555-61.
2003: Peter Danos; Bruno Baumann; Andrea Krämer; Hans-Gert Bernstein; Renate Stauch; Dieter Krell; Peter Falkai; Bernhard Bogerts
Volumes of association thalamic nuclei in schizophrenia: a postmortem study.
Schizophrenia research 2003;60(2-3):141-55.
2003: Larry J Seidman; Christos Pantelis; Matcheri S Keshavan; Stephen Faraone; Jill M Goldstein; Nicholas J Horton; Nikos Makris; Peter Falkai; Verne S Caviness; Ming T Tsuang
A review and new report of medial temporal lobe dysfunction as a vulnerability indicator for schizophrenia: a magnetic resonance imaging morphometric family study of the parahippocampal gyrus.
Schizophrenia bulletin 2003;29(4):803-30.
2003: Nadja Marić; Thomas Kamer; Thomas Schneider-Axmann; Indra Dani; Miroslava Jasović Gasić; Vladimir R Paunović; Peter Falkai
[Volumetric analysis of gray matter, white matter and cerebrospinal fluid space in schizophrenia].
Srpski arhiv za celokupno lekarstvo 2003;131(1-2):26-30.
2003: Wolfgang Wölwer; Peter Falkai; Marcus Streit; Wolfgang Gaebel
Trait characteristic of impaired visuomotor integration during Trail-Making Test B performance in schizophrenia.
Neuropsychobiology 2003;48(2):59-67.
2003: Wolfgang Gaebel; Peter Falkai
[DGPPN policy paper on quality assurance and guidelines. Current status and perspectives of guideline development].
Der Nervenarzt 2003;74(1):94-6.
2002: David Ames; John Camm; Peter Cook; Peter Falkai; Charles Gury; Rod Hurley; Gordon Johnson; Robert Piepho; Victor Vieweg
Cardiac risk of psychotropic drugs.
The Australian and New Zealand journal of psychiatry 2002;36(6):819-20.
2002: D Ames; J Camm; P Cook; Peter Falkai; Charles Gury; R Hurley; G Johnson; R Piepho; V Vieweg
[Minimizing the risks associated with QTc prolongation in people with schizophrenia. A consensus statement by the Cardiac Safety in Schizophrenia Group].
L'Encéphale 2002;28(6 Pt 1):552-62.
2002: Wolfgang Maier; Dirk Lichtermann; Petra Franke; Reinhard Heun; Peter Falkai; Marcella Rietschel
The dichotomy of schizophrenia and affective disorders in extended pedigrees.
Schizophrenia research 2002;57(2-3):259-66.
2002: Peter Falkai; William Honer; Daniela Alfter; Thomas Schneider-Axmann; Patrick Bussfeld; Joachim Cordes; Bettina Blank; Helmut Schönell; Helmuth Steinmetz; Wolfgang Maier; Ralf Tepest
The temporal lobe in schizophrenia from uni- and multiply affected families.
Neuroscience letters 2002;325(1):25-8.
2002: William Honer; Peter Falkai; Thomas A Bayer; Jane Xie; Lily Hu; Hong-Ying Li; Victoria Arango; J John Mann; andrew dwork; William S Trimble
Abnormalities of SNARE mechanism proteins in anterior frontal cortex in severe mental illness.
Cerebral cortex (New York, N.Y. : 1991) 2002;12(4):349-56.
2002: Peter Danos; Bruno Baumann; Hans-Gert Bernstein; Renate Stauch; Dieter Krell; Peter Falkai; Bernhard Bogerts
The ventral lateral posterior nucleus of the thalamus in schizophrenia: a post-mortem study.
Psychiatry research 2002;114(1):1-9.
2002: Ken Sawada; Clint Young; Alasdair M Barr; K Longworth; S Takahashi; Victoria Arango; J John Mann; andrew dwork; Peter Falkai; Anthony G Phillips; William Honer
Altered immunoreactivity of complexin protein in prefrontal cortex in severe mental illness.
Molecular psychiatry 2002;7(5):484-92.
2001: Frank Jessen; T Fries; C Kucharski; T Nishimura; Klaus Hoenig; Wolfgang Maier; Peter Falkai; Reinhard Heun
Amplitude reduction of the mismatch negativity in first-degree relatives of patients with schizophrenia.
Neuroscience letters 2001;309(3):185-8.
2001: Kai Vogeley; Patrick Bussfeld; Albert Newen; S Herrmann; Francesca Happé; Peter Falkai; Wolfgang Maier; N Jon Shah; Gereon R Fink; Karl Zilles
Mind reading: neural mechanisms of theory of mind and self-perspective.
NeuroImage 2001;14(1 Pt 1):170-81.
2001: Peter Falkai; Kai Vogeley; Wolfgang Maier
[Structural brain changes in patients with schizophrenic psychoses. From focal pathology to network disorder].
Der Nervenarzt 2001;72(5):331-41.
2001: Kai Vogeley; Ralf Tepest; Ute Pfeiffer; Thomas Schneider-Axmann; Wolfgang Maier; William Honer; Peter Falkai
Right frontal hypergyria differentiation in affected and unaffected siblings from families multiply affected with schizophrenia: a morphometric mri study.
The American journal of psychiatry 2001;158(3):494-6.
2000: Sibylle G Schwab; Joachim Hallmayer; Margot Albus; Bernard Lerer; GN Eckstein; M Borrmann; Ronnen Segman; Claudia Hanses; J Freymann; Avi Yakir; Mátyás Trixler; Peter Falkai; Marcella Rietschel; Wolfgang Maier; Dieter B Wildenauer
A genome-wide autosomal screen for schizophrenia susceptibility loci in 71 families with affected siblings: support for loci on chromosome 10p and 6.
Molecular psychiatry 2000;5(6):638-49.
2000: Y Kawasak; Kai Vogeley; V Jung; Ralf Tepest; H Hütte; A Schleicher; Peter Falkai
Automated image analysis of disturbed cytoarchitecture in Brodmann area 10 in schizophrenia: a post-mortem study.
Progress in neuro-psychopharmacology & biological psychiatry 2000;24(7):1093-104.
2000: Wolfgang Block; Thomas A Bayer; Ralf Tepest; Frank Träber; Marcella Rietschel; Daniel J Müller; Thomas G. Schulze; William Honer; Wolfgang Maier; Hans H Schild; Peter Falkai
Decreased frontal lobe ratio of N-acetyl aspartate to choline in familial schizophrenia: a proton magnetic resonance spectroscopy study.
Neuroscience letters 2000;289(2):147-51.
2000: Thomas A Bayer; M Schramm; Nicole Feldmann; M B Knable; Peter Falkai
Antidepressant drug exposure is associated with mRNA levels of tyrosine receptor kinase B in major depressive disorder.
Progress in neuro-psychopharmacology & biological psychiatry 2000;24(6):881-8.
2000: Peter Falkai; Thomas Schneider-Axmann; William Honer
Entorhinal cortex pre-alpha cell clusters in schizophrenia: quantitative evidence of a developmental abnormality.
Biological psychiatry 2000;47(11):937-43.
2000: Peter Falkai; Kai Vogeley
[The chances of new atypical substances].
Fortschritte der Neurologie-Psychiatrie 2000;68 Suppl 1():S32-7.
2000: Kai Vogeley; Thomas Schneider-Axmann; Ute Pfeiffer; Ralf Tepest; Thomas A Bayer; B Bogerts; William Honer; Peter Falkai
Disturbed gyrification of the prefrontal region in male schizophrenic patients: A morphometric postmortem study.
The American journal of psychiatry 2000;157(1):34-9.
1999: Petra Franke; Michael Gänsicke; S Schmitz; Peter Falkai; Wolfgang Maier
Differential memory span--abnormal lateralization pattern in schizophrenic patients and their siblings?
International journal of psychophysiology : official journal of the International Organization of Psychophysiology 1999;34(3):303-11.
1999: T A Bayer; Peter Falkai; Wolfgang Maier
Genetic and non-genetic vulnerability factors in schizophrenia: the basis of the "two hit hypothesis".
Journal of psychiatric research 1999;33(6):543-8.
1999: Wolfgang Maier; Dirk Lichtermann; Marcella Rietschel; T Held; Peter Falkai; M Wagner; S Schwab
[Genetics of schizophrenic disorders. New concepts and findings].
Der Nervenarzt 1999;70(11):955-69.
1999: Thomas A Bayer; P Jäkälä; Tobias Hartmann; R Egensperger; R Buslei; Peter Falkai; Konrad Beyreuther
Neural expression profile of alpha-synuclein in developing human cortex.
Neuroreport 1999;10(13):2799-803.
1999: Kai Vogeley; Martin Kurthen; Peter Falkai; Wolfgang Maier
Essential functions of the human self model are implemented in the prefrontal cortex.
Consciousness and cognition 1999;8(3):343-63.
1999: Thomas A Bayer; R Buslei; L Havas; Peter Falkai
Evidence for activation of microglia in patients with psychiatric illnesses.
Neuroscience letters 1999;271(2):126-8.
1999: Georg Northoff; H Waters; I Mooren; U Schlüter; S Diekmann; Peter Falkai; Bernhard Bogerts
Cortical sulcal enlargement in catatonic schizophrenia: a planimetric CT study.
Psychiatry research 1999;91(1):45-54.
1999: Thomas A Bayer; P Jäkälä; Tobias Hartmann; L Havas; C McLean; Janetta G Culvenor; Qiao-Xin Li; Colin L Masters; Peter Falkai; Konrad Beyreuther
Alpha-synuclein accumulates in Lewy bodies in Parkinson's disease and dementia with Lewy bodies but not in Alzheimer's disease beta-amyloid plaque cores.
Neuroscience letters 1999;266(3):213-6.
1999: Peter Falkai
Mirtazapine: other indications.
The Journal of clinical psychiatry 1999;60 Suppl 17():36-40; discussion 46-8.
1999: M Schramm; Peter Falkai; Ralf Tepest; Thomas Schneider-Axmann; R Przkora; Andreas Waha; Torsten Pietsch; Wolfgang Bonte; Thomas A Bayer
Stability of RNA transcripts in post-mortem psychiatric brains.
Journal of neural transmission (Vienna, Austria : 1996) 1999;106(3-4):329-35.
1999: William Honer; Peter Falkai; C Chen; Victoria Arango; J J Mann; andrew dwork
Synaptic and plasticity-associated proteins in anterior frontal cortex in severe mental illness.
Neuroscience 1999;91(4):1247-55.
1999: M Schramm; Peter Falkai; Torsten Pietsch; Iris Neidt; R Egensperger; Thomas A Bayer
Neural expression profile of Elav-like genes in human brain.
Clinical neuropathology 1999;18(1):17-22.
1998: M Schramm; Peter Falkai; Nicole Feldmann; M B Knable; Thomas A Bayer
Reduced tyrosine kinase receptor C mRNA levels in the frontal cortex of patients with schizophrenia.
Neuroscience letters 1998;257(2):65-8.
1998: Hans-Gert Bernstein; Dieter Krell; Bruno Baumann; Peter Danos; Peter Falkai; Silvia Diekmann; H Henning; Bernhard Bogerts
Morphometric studies of the entorhinal cortex in neuropsychiatric patients and controls: clusters of heterotopically displaced lamina II neurons are not indicative of schizophrenia.
Schizophrenia research 1998;33(3):125-32.
1998: Kai Vogeley; T Hobson; Thomas Schneider-Axmann; William Honer; B Bogerts; Peter Falkai
Compartmental volumetry of the superior temporal gyrus reveals sex differences in schizophrenia--a post-mortem study.
Schizophrenia research 1998;31(2-3):83-7.
1998: Geoffrey N Smith; Lili C Kopala; Jocelyne S Lapointe; G William MacEwan; Siemion Altman; Sean W Flynn; T Schneider; Peter Falkai; William Honer
Obstetric complications, treatment response and brain morphology in adult-onset and early-onset males with schizophrenia.
Psychological medicine 1998;28(3):645-53.
1998: Peter Danos; Bruno Baumann; Hans-Gert Bernstein; M Franz; Renate Stauch; Georg Northoff; Dieter Krell; Peter Falkai; Bernhard Bogerts
Schizophrenia and anteroventral thalamic nucleus: selective decrease of parvalbumin-immunoreactive thalamocortical projection neurons.
Psychiatry research 1998;82(1):1-10.
1998: Clint Young; K Arima; Jane Xie; Lily Hu; Thomas Beach; Peter Falkai; William Honer
SNAP-25 deficit and hippocampal connectivity in schizophrenia.
Cerebral cortex (New York, N.Y. : 1991) 1998;8(3):261-8.
1998: Hans-Gert Bernstein; A Stanarius; Bruno Baumann; H Henning; Dieter Krell; Peter Danos; Peter Falkai; Bernhard Bogerts
Nitric oxide synthase-containing neurons in the human hypothalamus: reduced number of immunoreactive cells in the paraventricular nucleus of depressive patients and schizophrenics.
Neuroscience 1998;83(3):867-75.
1998: R Przkora; Peter Falkai; Andreas von Deimling; Otmar D Wiestler; Margot Albus; Marcella Rietschel; Wolfgang Maier; Thomas A Bayer
Analysis of a polymorphism in the tuberous sclerosis (TSC2) gene does not predispose to schizophrenia.
European archives of psychiatry and clinical neuroscience 1998;248(6):314-5.
1997: Geoffrey N Smith; Sean W Flynn; Lili C Kopala; A S Bassett; Jocelyne S Lapointe; Peter Falkai; William Honer
A comprehensive method of assessing routine CT scans in schizophrenia.
Acta psychiatrica Scandinavica 1997;96(5):395-401.
1997: Frank Schneider; Wolfgang Gaebel; Peter Falkai; Michaela Jänner
[Graduate and continuing education seminars in psychiatry and psychotherapy].
Der Nervenarzt 1997;68(5):441-2.
1997: William Honer; Peter Falkai; C Young; T Wang; Jane Xie; Jennifer Bonner; Lily Hu; Gabrielle L Boulianne; Z Luo; William S Trimble
Cingulate cortex synaptic terminal proteins and neural cell adhesion molecule in schizophrenia.
Neuroscience 1997;78(1):99-110.
1996: William Honer; Anne S Bassett; Peter Falkai; Thomas Beach; Jocelyne S Lapointe
A case study of temporal lobe development in familial schizophrenia.
Psychological medicine 1996;26(1):191-5.
1995: William Honer; Anne S Bassett; E Squires-Wheeler; Peter Falkai; Geoffrey N Smith; Jocelyne S Lapointe; C Canero; Donna Jane Lang
The temporal lobes, reversed asymmetry and the genetics of schizophrenia.
Neuroreport 1995;7(1):221-4.
1995: C Wurthmann; Bernhard Bogerts; Peter Falkai
Brain morphology assessed by computed tomography in patients with geriatric depression, patients with degenerative dementia, and normal control subjects.
Psychiatry research 1995;61(2):103-11.
1995: Peter Falkai; T Schneider; B Greve; Eckhard Klieser; B Bogerts
Reduced frontal and occipital lobe asymmetry on the CT-scans of schizophrenic patients. Its specificity and clinical significance.
Journal of neural transmission. General section 1995;99(1-3):63-77.
1995: Peter Falkai; B Bogerts; T Schneider; B Greve; U Pfeiffer; K Pilz; C Gonsiorzcyk; C Majtenyi; I Ovary
Disturbed planum temporale asymmetry in schizophrenia. A quantitative post-mortem study.
Schizophrenia research 1995;14(2):161-76.
1994: William Honer; Anne S Bassett; Geoffrey N Smith; Jocelyne S Lapointe; Peter Falkai
Temporal lobe abnormalities in multigenerational families with schizophrenia.
Biological psychiatry 1994;36(11):737-43.
1994: A Kleinschmidt; Peter Falkai; Y Huang; T Schneider; G Fürst; H Steinmetz
In vivo morphometry of planum temporale asymmetry in first-episode schizophrenia.
Schizophrenia research 1994;12(1):9-18.
1993: B Bogerts; Peter Falkai; B Greve; T Schneider; U Pfeiffer
The neuropathology of schizophrenia: past and present.
Journal für Hirnforschung 1993;34(2):193-205.
1992: G Degreef; B Bogerts; Peter Falkai; B Greve; George Lantos; Manzar Ashtari; J Lieberman
Increased prevalence of the cavum septum pellucidum in magnetic resonance scans and post-mortem brains of schizophrenic patients.
Psychiatry research 1992;45(1):1-13.
1992: Peter Falkai; B Bogerts; B Greve; U Pfeiffer; B Machus; B Fölsch-Reetz; C Majtenyi; I Ovary
Loss of sylvian fissure asymmetry in schizophrenia. A quantitative post mortem study.
Schizophrenia research 1992;7(1):23-32.
1991: B Bogerts; Peter Falkai; B Greve
Evidence of reduced temporolimbic structure volumes in schizophrenia.
Archives of general psychiatry 1991;48(10):956-8.
1990: B Bogerts; Peter Falkai; M Haupts; B Greve; S Ernst; U Tapernon-Franz; U Heinzmann
Post-mortem volume measurements of limbic system and basal ganglia structures in chronic schizophrenics. Initial results from a new brain collection.
Schizophrenia research 1990;3(5-6):295-301.
1988: Peter Falkai; B Bogerts; M Rozumek
Limbic pathology in schizophrenia: the entorhinal region--a morphometric study.
Biological psychiatry 1988;24(5):515-21.